HK1052529A1 - High order nucleic acid based structures - Google Patents
High order nucleic acid based structuresInfo
- Publication number
- HK1052529A1 HK1052529A1 HK03104743.9A HK03104743A HK1052529A1 HK 1052529 A1 HK1052529 A1 HK 1052529A1 HK 03104743 A HK03104743 A HK 03104743A HK 1052529 A1 HK1052529 A1 HK 1052529A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- nucleic acid
- high order
- acid based
- based structures
- order nucleic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
- C12N2310/151—Nucleic acids forming more than 2 strands, e.g. TFOs more than 3 strands, e.g. tetrads, H-DNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/52—Physical structure branched
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9926810.4A GB9926810D0 (en) | 1999-11-13 | 1999-11-13 | High order nucleic acid-based structures |
GB0011126A GB0011126D0 (en) | 2000-05-10 | 2000-05-10 | High order nucleic acid-based structures |
PCT/EP2000/011197 WO2001036624A1 (en) | 1999-11-13 | 2000-11-13 | High order nucleic acid based structures |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1052529A1 true HK1052529A1 (en) | 2003-09-19 |
Family
ID=26244234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK03104743.9A HK1052529A1 (en) | 1999-11-13 | 2003-07-03 | High order nucleic acid based structures |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1228201A1 (en) |
JP (1) | JP2003522524A (en) |
KR (1) | KR20020059727A (en) |
CN (1) | CN1390253A (en) |
AU (1) | AU782880B2 (en) |
BR (1) | BR0015484A (en) |
CA (1) | CA2391084A1 (en) |
CZ (1) | CZ20021472A3 (en) |
HK (1) | HK1052529A1 (en) |
HU (1) | HUP0203914A2 (en) |
MX (1) | MXPA02004727A (en) |
NO (1) | NO20022231L (en) |
PL (1) | PL358811A1 (en) |
RU (1) | RU2002113755A (en) |
SK (1) | SK6042002A3 (en) |
WO (1) | WO2001036624A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000039304A2 (en) | 1998-12-31 | 2000-07-06 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
JP5033303B2 (en) | 2001-07-05 | 2012-09-26 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | Polynucleotides encoding polypeptides with antigenic type C HIV, polypeptides and uses thereof |
US9796749B2 (en) | 2011-08-05 | 2017-10-24 | President And Fellows Of Harvard College | Compositions and methods relating to nucleic acid nano- and micro-technology |
US10604543B2 (en) | 2012-07-24 | 2020-03-31 | President And Fellows Of Harvard College | Self-assembly of nucleic acid nanostructures |
WO2014074597A1 (en) | 2012-11-06 | 2014-05-15 | President And Fellows Of Harvard College | Compositions and methods relating to complex nucleic acid nanostructures |
CN105705143A (en) * | 2013-11-08 | 2016-06-22 | 达娜-法勃肿瘤研究所公司 | Nucleic acid nanostructures for in vivo agent delivery |
KR20170009929A (en) | 2014-05-22 | 2017-01-25 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | Scalable nucleic acid-based nanofabrication |
US11414694B2 (en) | 2016-03-11 | 2022-08-16 | Children's Medical Center Corporation | Nucleic acid nanoswitch catenanes |
US11254972B2 (en) | 2016-08-02 | 2022-02-22 | President And Fellows Of Harvard College | Crisscross cooperative self-assembly |
TWI743518B (en) * | 2018-07-12 | 2021-10-21 | 大陸商百藥智達(北京)納米生物技術有限公司 | Nucleic acid nanoparticles, pharmaceutical composition thereof, medicine comprising doxorubicin and preparation method thereof |
CN110711254B (en) * | 2018-07-12 | 2022-07-26 | 百药智达(北京)纳米生物技术有限公司 | Nucleic acid nanoparticles and pharmaceutical compositions comprising the same |
CN110960534B (en) * | 2018-09-30 | 2022-07-26 | 百药智达(北京)纳米生物技术有限公司 | Medicine containing pentafluorouracil, preparation method thereof, pharmaceutical composition and application thereof |
CN110960542B (en) * | 2018-09-30 | 2022-07-26 | 百药智达(北京)纳米生物技术有限公司 | Medicament containing pirarubicin, preparation method thereof, pharmaceutical composition and application thereof |
CN110960530B (en) * | 2018-09-30 | 2022-07-22 | 百药智达(北京)纳米生物技术有限公司 | Tacrine-containing medicine, preparation method thereof, pharmaceutical composition and application thereof |
CN110960536B (en) * | 2018-09-30 | 2022-07-26 | 百药智达(北京)纳米生物技术有限公司 | Aspirin-containing medicine, preparation method, pharmaceutical composition and application thereof |
CN110960690B (en) * | 2018-09-30 | 2022-07-22 | 百药智达(北京)纳米生物技术有限公司 | Medicine containing epirubicin, preparation method thereof, pharmaceutical composition and application thereof |
CN111053765B (en) * | 2018-10-16 | 2022-07-26 | 百药智达(北京)纳米生物技术有限公司 | Medicine containing paclitaxel, preparation method, pharmaceutical composition and application thereof |
CN111068065B (en) * | 2018-10-22 | 2022-07-26 | 百药智达(北京)纳米生物技术有限公司 | Drug containing oxaliplatin, preparation method thereof, pharmaceutical composition and application thereof |
CN111084887B (en) * | 2018-10-23 | 2022-07-22 | 百药智达(北京)纳米生物技术有限公司 | Flavone-containing medicine, preparation method thereof, medicine composition and application |
CN111096965B (en) * | 2018-10-29 | 2022-07-26 | 百药智达(北京)纳米生物技术有限公司 | Medicine containing dihydroartemisinin, preparation method thereof, medicine composition and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985000813A1 (en) * | 1983-08-03 | 1985-02-28 | The Research Foundation Of State University Of New | Nucleic acid branched junctions with precisely defined migrational mobility |
US5386020A (en) * | 1991-01-10 | 1995-01-31 | New York University | Multiply connected, three-dimensional nucleic acid structures |
US5278051A (en) * | 1991-12-12 | 1994-01-11 | New York University | Construction of geometrical objects from polynucleotides |
US6072044A (en) * | 1996-04-26 | 2000-06-06 | New York University | Nanoconstructions of geometrical objects and lattices from antiparallel nucleic acid double crossover molecules |
-
2000
- 2000-11-13 BR BR0015484-9A patent/BR0015484A/en not_active IP Right Cessation
- 2000-11-13 MX MXPA02004727A patent/MXPA02004727A/en unknown
- 2000-11-13 CZ CZ20021472A patent/CZ20021472A3/en unknown
- 2000-11-13 EP EP00983130A patent/EP1228201A1/en not_active Withdrawn
- 2000-11-13 CN CN00815433A patent/CN1390253A/en active Pending
- 2000-11-13 HU HU0203914A patent/HUP0203914A2/en unknown
- 2000-11-13 SK SK604-2002A patent/SK6042002A3/en not_active Application Discontinuation
- 2000-11-13 AU AU20001/01A patent/AU782880B2/en not_active Ceased
- 2000-11-13 CA CA002391084A patent/CA2391084A1/en not_active Abandoned
- 2000-11-13 WO PCT/EP2000/011197 patent/WO2001036624A1/en not_active Application Discontinuation
- 2000-11-13 JP JP2001538503A patent/JP2003522524A/en active Pending
- 2000-11-13 KR KR1020027006140A patent/KR20020059727A/en not_active Application Discontinuation
- 2000-11-13 PL PL00358811A patent/PL358811A1/en unknown
- 2000-11-13 RU RU2002113755/04A patent/RU2002113755A/en unknown
-
2002
- 2002-05-10 NO NO20022231A patent/NO20022231L/en unknown
-
2003
- 2003-07-03 HK HK03104743.9A patent/HK1052529A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1390253A (en) | 2003-01-08 |
NO20022231D0 (en) | 2002-05-10 |
MXPA02004727A (en) | 2002-08-30 |
JP2003522524A (en) | 2003-07-29 |
EP1228201A1 (en) | 2002-08-07 |
HUP0203914A2 (en) | 2003-03-28 |
AU782880B2 (en) | 2005-09-08 |
WO2001036624A1 (en) | 2001-05-25 |
NO20022231L (en) | 2002-05-10 |
CA2391084A1 (en) | 2001-05-25 |
PL358811A1 (en) | 2004-08-23 |
KR20020059727A (en) | 2002-07-13 |
CZ20021472A3 (en) | 2002-07-17 |
SK6042002A3 (en) | 2002-12-03 |
AU2000101A (en) | 2001-05-30 |
BR0015484A (en) | 2002-07-02 |
RU2002113755A (en) | 2004-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL343518A1 (en) | (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides | |
HUP0202221A1 (en) | Tenascin-c nucleic acid lagands | |
HUP0201438A2 (en) | Dna vaccine - pcv | |
IL149491A0 (en) | Nucleic acid-containing complex | |
PL358811A1 (en) | High order nucleic acid based structures | |
EP1114827A4 (en) | Novel nucleic acid base pair | |
HUP0105208A3 (en) | Gene therapy-1 | |
HUP0203848A3 (en) | Nucleic acid vaccination | |
IL146332A0 (en) | PrP-LIKE GENE | |
IL149679A0 (en) | Nucleic acid construct and methods utilizing the same | |
GB9917875D0 (en) | Nucleic acid constructs | |
GB9905644D0 (en) | Dna | |
EP1215284A4 (en) | Tsg-like gene | |
IL132710A0 (en) | Catalytic nucleic acid sequences | |
GB9823481D0 (en) | Nucleic acid | |
GB9822490D0 (en) | Nucleic acid | |
EP1218036A4 (en) | Cell based assay | |
IL130606A0 (en) | An array of nucleic acid sequence | |
AUPQ403299A0 (en) | Nucleic acid sequence | |
AU4107500A (en) | Nucleic acid combination | |
GB0026731D0 (en) | Nucleic acid modification | |
GB0023519D0 (en) | Nucleic acid modification | |
IL128483A0 (en) | Nucleic acid molecules | |
AUPQ423599A0 (en) | Novel nucleic acid molecules - II | |
GB9925696D0 (en) | Detecting nucleic acid |